|
Status |
Public on May 26, 2016 |
Title |
Patient-derived xenograft platform for metastatic melanoma |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
27320919 |
|
Submission date |
Oct 05, 2015 |
Last update date |
May 15, 2019 |
Contact name |
Oscar Krijgsman |
E-mail(s) |
o.krijgsman@nki.nl, oscarkrijgsman@gmail.com
|
Phone |
31205122028
|
Organization name |
Netherlands Cancer Institute
|
Department |
Molecular Oncology and Immunology
|
Lab |
Peeper
|
Street address |
Plesmanlaan 121
|
City |
Amsterdam |
State/province |
Outside the US or Canada |
ZIP/Postal code |
1066CX |
Country |
Netherlands |
|
|
Platforms (2) |
GPL11154 |
Illumina HiSeq 2000 (Homo sapiens) |
GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
|
Samples (18)
|
|
This SuperSeries is composed of the following SubSeries: |
GSE66539 |
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. |
GSE73737 |
Patient-derived xenograft platform for metastatic melanoma: RNA sequencing of 4 melanoma PDX samples |
|
Relations |
BioProject |
PRJNA297786 |